ELOCTATE 1000

Land: Israel

Språk: engelska

Källa: Ministry of Health

Aktiva substanser:

COAGULATION FACTOR VIII

Tillgänglig från:

SANOFI - AVENTIS ISRAEL LTD

ATC-kod:

B02BD05

Läkemedelsform:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Sammansättning:

COAGULATION FACTOR VIII 1000 IU

Administreringssätt:

I.V

Receptbelagda typ:

Required

Tillverkad av:

BIOGEN IDEC LIMITED , UK

Terapiområde:

COAGULATION FACTOR VII

Terapeutiska indikationer:

ELOCTATE [Antihemophilic Factor (Recombinant Fc Fusion Protein)] is a long-acting antihemophilic factor (recombinant) indicated in adults and children12 years of age and older with Hemophilia A (congenital factor VIII deficiency) for:• Control and prevention of bleeding episodes.• Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.• Perioperative management (surgical prophylaxis).ELOCTATE is not indicated for the treatment of von Willebrand disease.

Tillstånd datum:

2017-01-09